ArticleFrontiers in immunology2024

The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.

Chao-Xu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.